JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 48 filers reported holding JUNIPER PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $66,000 | -88.7% | 7,649 | -86.7% | 0.00% | – |
Q1 2018 | $584,000 | +128.1% | 57,574 | +8.7% | 0.00% | – |
Q4 2017 | $256,000 | +5.8% | 52,958 | -0.4% | 0.00% | – |
Q3 2017 | $242,000 | -37.9% | 53,156 | -31.1% | 0.00% | – |
Q2 2017 | $390,000 | -45.7% | 77,101 | -49.0% | 0.00% | – |
Q1 2017 | $718,000 | +10.8% | 151,154 | +30.7% | 0.00% | – |
Q4 2016 | $648,000 | +81.0% | 115,606 | +79.3% | 0.00% | – |
Q3 2016 | $358,000 | -22.0% | 64,477 | -1.7% | 0.00% | – |
Q2 2016 | $459,000 | -26.3% | 65,567 | -30.5% | 0.00% | – |
Q1 2016 | $623,000 | -71.4% | 94,357 | -55.4% | 0.00% | -100.0% |
Q4 2015 | $2,178,000 | -43.5% | 211,413 | -35.4% | 0.00% | 0.0% |
Q3 2015 | $3,854,000 | +452.1% | 327,189 | +329.2% | 0.00% | – |
Q2 2015 | $698,000 | – | 76,231 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 481,459 | $5,672,000 | 2.05% |
Krensavage Asset Management, LLC | 279,717 | $3,295,000 | 1.19% |
EAM Investors, LLC | 145,898 | $1,719,000 | 0.27% |
PERRITT CAPITAL MANAGEMENT INC | 93,000 | $1,096,000 | 0.23% |
TFS CAPITAL LLC | 99,823 | $1,176,000 | 0.11% |
Bellevue Asset Management AG | 50,000 | $589,000 | 0.10% |
CADENCE CAPITAL MANAGEMENT LLC | 88,232 | $1,039,000 | 0.07% |
Spark Investment Management LLC | 39,200 | $461,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 100,564 | $1,185,000 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 35,599 | $419,000 | 0.03% |